SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-278720
Filing Date
2015-08-05
Accepted
2015-08-05 16:23:34
Documents
3
Period of Report
2015-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d93154d8k.htm 8-K 13206
2 EX-99.1 d93154dex991.htm EX-99.1 88312
3 GRAPHIC g93154ex99_1logo.jpg GRAPHIC 17632
  Complete submission text file 0001193125-15-278720.txt   127192
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34921 | Film No.: 151029278
SIC: 2834 Pharmaceutical Preparations